CONMED Corporation (CNMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

CONMED Corporation

NYSE: CNMD · Real-Time Price · USD
55.00
0.31 (0.57%)
At close: Sep 05, 2025, 3:59 PM
54.97
-0.06%
After-hours: Sep 05, 2025, 05:07 PM EDT

CONMED Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.31B 1.24B 1.05B 1.01B
Cost of Revenue
573.98M 568.5M 474.23M 442.6M
Gross Profit
733.03M 676.25M 571.25M 568.04M
Operating Income
200.33M 130.79M 70.05M 37.85M
Interest Income
n/a n/a n/a n/a
Pretax Income
163.03M 80.83M -70.86M 73.11M
Net Income
132.42M 64.46M -80.58M 62.54M
Selling & General & Admin
478.28M 504.71M 454.04M 414.75M
Research & Development
54.43M 52.6M 47.15M 43.56M
Other Expenses
n/a n/a n/a -1.13M
Operating Expenses
532.71M 555.64M 501.19M 458.32M
Interest Expense
37.3M 39.77M 28.91M 35.48M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.11B 1.12B 975.42M 900.92M
Income Tax Expense
30.61M 16.37M 9.72M 10.56M
Shares Outstanding (Basic)
30.85M 30.67M 30.04M 29.16M
Shares Outstanding (Diluted)
31.11M 31.55M 30.04M 32.22M
EPS (Basic)
4.29 2.10 -2.68 2.14
EPS (Diluted)
4.26 2.04 -2.68 1.94
EBITDA
272.18M 192.48M 7.8M 158.38M
EBIT
200.33M 120.6M -41.96M 108.59M
Depreciation & Amortization
51.3M 51.4M 49.76M 49.79M